Reversed-phase thin-layer chromatography of three new oral antidiabetics and densitometric determination of pioglitazone

Journal of Liquid Chromatography and Related Technologies

Volumn 27, Issue 13, 2004, Pages 2057-2070

  Gumieniczek, Anna ^a   Hopkała, Hanna ^a   Berecka, Anna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Densitometry; Oral antidiabetics; Pioglitazone; Reversed phase HPTLC; Separation; Tablets

Indexed keywords

CHEMICAL BONDS; DENSITOMETERS; DRUG PRODUCTS; FLOW OF FLUIDS; PH EFFECTS;

ANTIDIABETICS; MOBILE PHASES;

THIN LAYER CHROMATOGRAPHY;

DIOXANE; ORAL ANTIDIABETIC AGENT; PHOSPHATE; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE;

ARTICLE; CALIBRATION; CORRELATION COEFFICIENT; DENSITOMETRY; DRUG DETERMINATION; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; PH; QUANTITATIVE ANALYSIS; REVERSED PHASE THIN LAYER CHROMATOGRAPHY; TABLET; THIN LAYER CHROMATOGRAPHY; WAVEFORM;

EID: 4043059370     PISSN: 10826076     EISSN: None     Source Type: Journal    
DOI: 10.1081/JLC-120039418     Document Type: Article

References (20)

1. Madhavan, G.; Chakrabarti, R.; Kumar, S.K.B.; Misra, P.; Mamidi, R.N.V.S.; Balraju, V.; Kasiram, K.; Babu, R.K.; Suresh, J.; Lohray, B.B.; Lohray, V.B.; Iqbal, J.; Rajagopalan, R. Novel phthalazinone and benzooxazinone containing thiazolidinediones as antidiabetic and hypolipidemic agents. Eur. J. Med. Chem. 2001, 36, 627-637.
2. Bailey, C.J. Potential new treatments for type 2 diabetes. Trends Pharmacol. Sci. 2000, 21, 259-265.
3. Gumieniczek, A.; Hopkala, H.; Berecka, A.; Kowalczuk, D. Normal and reversed-phase thin-layer chromatography of seven oral antidiabetic agents. J. Planar Chromatogr.-Mod. TLC 2003, 16, 271-275.
4. Sane, R.T.; Francis, M.; Moghe, A.; Khedkar, S.; Anerao, A. High performance thin-layer chromatographic determination of rosiglitazone in its dosage form. J. Planar Chromatogr.-Mod. TLC 2002, 15, 192-195.
5. Gumieniczek, A.; Berecka, A.; Hopkala, H.; Mroczek, T. Rapid HPTLC determination of rosiglitazone in pharmaceutical formulations. J. Liq. Chromatogr. Relat. Technol. 2003, 26, 3301-3308.
6. Radhakrishna, T.; Sreenivas, R.D.; Om, R.G. Determination of pioglitazone hydrochloride in bulk and pharmaceutical formulations by HPLC and MEKC methods. J. Pharm. Biomed. Anal. 2002, 29, 593-607.
7. Dai, J.; Jin, W.; Liu, Y. Study on determination of related substances of pioglitazone hydrochloride by RP-HPLC. Yaowu Fenxi Zazhi 2001, 21, 36-39.
8. Zhong, W.Z.; Williams, M.G. Simultaneous quantitation of pioglitazone and its metabolites in human serum by liquid chromatography and solid phase extraction. J. Pharm. Biomed. Anal. 1996, 14, 465-473.
9. Yamashita, K.; Murakami, H.; Okuda, T.; Motohashi, M. High performance liquid chromatographic determination of pioglitazone and its metabolites in human serum and urine. J. Chromatogr. B 1996, 677, 141-146.
10. Xue, Y.J.; Turner, K.C.; Meeker, J.B.; Pursley, J.; Arnold, M.; Unger, S. Quantitative determination of pioglitazone in human serum by direct-injection high performance liquid chromatography mass spectrometry and its application to a bioequivalence study. J. Chromatogr. B 2003, 795, 215-226.
11. Lin, Z.J.; Ji, W.; Desai-Krieger, D.; Shum, L. Simultaneous determination of pioglitazone and its two active metabolites in human plasma by LC-MS/MS. J. Pharm. Biomed. Anal. 2003, 33, 101-108.
12. Radhakrishna, T.; Satyanarayana, J.; Satyanarayana, A. LC determination of rosiglitazone in bulk and pharmaceutical formulation. J. Pharm. Biomed. Anal. 2002, 29, 873-880.
13. Wei, S.; Zhang, Z. RP-HPLC determination of rosiglitazone in plasma. Yaowu Fenxi Zazhi 2001, 21, 365-366.
14. Muxlow, A.M.; Fowles, S.; Russell, P. Automated high performance liquid chromatography method for the determination of rosiglitazone in human plasma. J. Chromatogr. B 2001, 752, 77-84.
15. Abbott, R.W.; Allen, G.D.; Rhodes, G. Chiral HPLC analysis of BRL 49653 and its enantiomers in mouse, rat, dog, and human plasma. Methodol. Surv. Bioanal. Drugs 1994, 23, 255-256.
16. Gaffney, M.H.; Allen, G.D.; Abbott, R.W.; Deeks, N.J.; Hollis, F.J.; Rhodes, G. Quantification of BRL 49653 in rat and dog plasma with fluorescence detection. Methodol. Surv. Bioanal. Drugs 1994, 23, 251-254.
17. Kolte, B.L.; Raut, B.B.; Deo, A.A.; Bagool, M.A.; Shide, D.B. Liquid chromatographic method for the determination of rosiglitazone in human plasma. J. Chromatogr. B 2003, 788, 37-44.
18. Mamidi, R.; Chaluvadi, M.R.; Benjamin, B.; Ramesh, M.; Katneni, K.; Babu, A.P.; Bhanduri, J.; Rao, N.; Rajagopalan, R. HPLC method for the determination of rosiglitazone in human plasma and its application in a clinical pharmacokinetic study. Arzneim.-Forsch. 2002, 52, 560-564.
19. Ji, H.; Xie, L.; Yan, M.; Zhang, L.; Huang, X.; Liu, X. Determination of repaglinide in plasma by HPLC and its pharmacokinetics in men. Zhongguo Yaoke Daxue Xuebao 2001, 32, 30-33.
20. Greischel, A.; Beschke, K.; Rapp, H.; Roth, W. Quantitation of the new hypoglycaemic agent AG-EE 388 ZW in human plasma by automated high performance liquid chromatography with electrochemical detection. J. Chromatogr. 1991, 568, 246-252.